Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-109869·Commander Aggregator, LP
Schedule 13D ownership disclosure
Compass Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 20454B104
Event date: 2025-08-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Commander Aggregator, LPReported CIK 0001953093
Shares: 7,788,150 · Class: 4.5%
- Enavate Sciences, LPReported CIK 0001953098
Shares: 7,788,150 · Class: 4.5%
- Enavate Sciences GP, LLCReported CIK 0001953107
Shares: 7,788,150 · Class: 4.5%
- Enavate Sciences Holdings, LLC
Shares: 7,788,150 · Class: 4.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-109869
- Form type
- SCHEDULE 13D/A
- Filer
- Commander Aggregator, LP
- CIK
- CIK 1953093
- Filed
- Aug 18, 2025
- Reporting period
- Aug 14, 2025
- Description
- Schedule 13D beneficial ownership